Literature DB >> 23672305

Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia.

Lisa M Faulcon, Zongming Fu, Pratima Dulloor, Emily Barron-Casella, William Savage, Jacky M Jennings, Jennifer E Van Eyk, Michael Debaun, James F Casella, Allen Everett.   

Abstract

Entities:  

Keywords:  L-selectin; Thrombospondin 1; biomarkers; sickle cell disease; silent cerebral infarcts

Mesh：

Substances：

Year:  2013        PMID： 23672305      PMCID： PMC4391368          DOI： 10.1111/bjh.12374

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Moderation of the platelet releasate response by aspirin.

Authors:  Judith A Coppinger; Roisin O'Connor; Kieran Wynne; Michelle Flanagan; Matthew Sullivan; Patricia B Maguire; Desmond J Fitzgerald; Gerard Cagney
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

2.  Design of the silent cerebral infarct transfusion (SIT) trial.

Authors:  James F Casella; Allison A King; Bruce Barton; Desiree A White; Michael J Noetzel; Rebecca N Ichord; Cindy Terrill; Deborah Hirtz; Robert C McKinstry; John J Strouse; Thomas H Howard; Thomas D Coates; Caterina P Minniti; Andrew D Campbell; Bruce A Vendt; Harold Lehmann; Michael R Debaun
Journal:  Pediatr Hematol Oncol       Date:  2010-03       Impact factor: 1.969

3.  Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin.

Authors:  C A Hillery; M C Du; W C Wang; J P Scott
Journal:  Br J Haematol       Date:  2000-05       Impact factor: 6.998

Review 4.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

5.  Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.

Authors:  Françoise Bernaudin; Suzanne Verlhac; Cécile Arnaud; Annie Kamdem; Sylvie Chevret; Isabelle Hau; Lena Coïc; Emmanuella Leveillé; Elisabeth Lemarchand; Emmanuelle Lesprit; Isabelle Abadie; Nadia Medejel; Fouad Madhi; Sophie Lemerle; Sandra Biscardi; Josiane Bardakdjian; Frédéric Galactéros; Martine Torres; Mathieu Kuentz; Christelle Ferry; Gérard Socié; Philippe Reinert; Christophe Delacourt
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

6.  Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

Authors:  Michael R DeBaun; Sharada A Sarnaik; Mark J Rodeghier; Caterina P Minniti; Thomas H Howard; Rathi V Iyer; Baba Inusa; Paul T Telfer; Melanie Kirby-Allen; Charles T Quinn; Françoise Bernaudin; Gladstone Airewele; Gerald M Woods; Julie Ann Panepinto; Beng Fuh; Janet K Kwiatkowski; Allison A King; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Hernan Sabio; Corina E Gonzalez; Suzanne L Saccente; Karen A Kalinyak; John J Strouse; Jason M Fixler; Mae O Gordon; J Phillip Miller; Michael J Noetzel; Rebecca N Ichord; James F Casella
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

7.  Plasma glial fibrillary acidic protein levels in children with sickle cell disease.

Authors:  William J Savage; Emily Barron-Casella; Zongming Fu; Pratima Dulloor; Lisa Williams; Barbara J Crain; Desiree A White; Jacky M Jennings; Jennifer E Van Eyk; Michael R Debaun; Allen Everett; James F Casella
Journal:  Am J Hematol       Date:  2011-05       Impact factor: 10.047

8.  Acute silent cerebral ischemic events in children with sickle cell anemia.

Authors:  Charles T Quinn; Robert C McKinstry; Michael M Dowling; William S Ball; Michael A Kraut; James F Casella; Nomazulu Dlamini; Rebecca N Ichord; Lori C Jordan; Fenella J Kirkham; Michael J Noetzel; E Steve Roach; John J Strouse; Janet L Kwiatkowski; Deborah Hirtz; Michael R DeBaun
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

9.  Silent infarcts in young children with sickle cell disease.

Authors:  Janet L Kwiatkowski; Robert A Zimmerman; Avrum N Pollock; Wendy Seto; Kim Smith-Whitley; Justine Shults; Anne Blackwood-Chirchir; Kwaku Ohene-Frempong
Journal:  Br J Haematol       Date:  2009-06-04       Impact factor: 6.998

10.  Daytime steady-state haemoglobin desaturation is a risk factor for overt stroke in children with sickle cell anaemia.

Authors:  Charles T Quinn; James W Sargent
Journal:  Br J Haematol       Date:  2007-11-27       Impact factor: 6.998
  10 in total
  8 in total

1.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

Review 2.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

Review 3.  Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.

Authors:  Natasha M Rogers; Maryam Sharifi-Sanjani; Gábor Csányi; Patrick J Pagano; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2014-01-11       Impact factor: 11.583

Review 4.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

5.  Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia.

Authors:  Seethal A Jacob; Enrico M Novelli; Jeffrey S Isenberg; Melanie E Garrett; Yanxia Chu; Karen Soldano; Kenneth I Ataga; Marilyn J Telen; Allison Ashley-Koch; Mark T Gladwin; Yingze Zhang; Gregory J Kato
Journal:  Am J Hematol       Date:  2017-02-03       Impact factor: 10.047

6.  Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells.

Authors:  Rosi Bissinger; Polina Petkova-Kirova; Olga Mykhailova; Per-Arne Oldenborg; Elena Novikova; David A Donkor; Thomas Dietz; Abdulla Al Mamun Bhuyan; William P Sheffield; Marijke Grau; Ferruh Artunc; Lars Kaestner; Jason P Acker; Syed M Qadri
Journal:  Cell Commun Signal       Date:  2020-09-18       Impact factor: 5.712

7.  Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease.

Authors:  Eboni I Lance; Lisa M Faulcon; Zongming Fu; Jun Yang; Donna Whyte-Stewart; John J Strouse; Emily Barron-Casella; Kimberly Jones; Jennifer E Van Eyk; James F Casella; Allen D Everett
Journal:  Proteomics Clin Appl       Date:  2021-05-24       Impact factor: 3.603

8.  Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction.

Authors:  Sanjay Tewari; George Renney; John Brewin; Kate Gardner; Fenella Kirkham; Baba Inusa; James E Barrett; Stephan Menzel; Swee Lay Thein; Malcolm Ward; David C Rees
Journal:  Haematologica       Date:  2018-03-15       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.